A REVIEW OF NAV1.7 INHIBITOR

can lead to powerful efficacy, a longer duration in plasma or even the focus on tissues may perhaps contribute to strong efficacy. As talked over from the Xenon/Genentech group,one hundred and one compounds with sharp PK profiles (significant blood amount peaks) would add to in vivoThis section collects any knowledge citations, info availability st